Great Valley Advisor Group, Inc. Gsk PLC Transaction History

Great Valley Advisor Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$40.23 - $47.74 $547,610 - $649,836	-13,612 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $92,340 - $107,611	-2,375 Reduced 14.86%	13,612 $600,000
Q3 2021 Oct 14, 2021	BUY	$38.79 - $43.16 $45,888 - $51,058	1,183 Added 7.99%	15,987 $611,000
Q2 2021 Jul 27, 2021	BUY	$36.52 - $41.46 $50,178 - $56,966	1,374 Added 10.23%	14,804 $589,000
Q1 2021 Apr 20, 2021	BUY	$34.27 - $40.01 $125,428 - $146,436	3,660 Added 37.46%	13,430 $479,000
Q4 2020 Jan 29, 2021	BUY	$34.07 - $39.94 $332,863 - $390,213	9,770 New	9,770 $360,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.